Thy-1-mediated activation of rat mast cells: the role of Thy-1 membrane microdomains

. 1996 Jan ; 87 (1) : 141-8.

Jazyk angličtina Země Velká Británie, Anglie Médium print

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid08666426

The glycosyl-phosphatidylinositol (GPI)-anchored glycoprotein Thy-1 is one of the most abundant molecules expressed on the surface of rat mast cells and rat basophilic leukemia (RBL) cells. The finding that Thy-1 from detergent-solubilized RBL-2H3 cells forms complexes with src-related protein-tyrosine kinase p56/p53lyn suggested that this kinase may play a key role in Thy-1-mediated mast-cell activation. The molecular mechanism of this activation is, however, unknown. Here we show that in RBL-2H3-derived cells extracted by the standard procedure with several non-ionic detergents, the majority of Thy-1 and p56/p53lyn were not released into postnuclear supernatant but remained associated with the detergent-resistant cytoskeletal/nuclear fraction. Pretreatment of the cells with the cholesterol-complexing agents, saponin or digitonin, resulted in complete solubilization of Thy-1 and p56/p53lyn in non-ionic detergents and dissociation of the complexes; this implies that cholesterol plays a crucial role in stabilization of the complexes. This conclusion was supported by double immunofluorescence colocalization experiments which also allowed us to estimate the size of the insoluble complexes to be about 0.1 micron. Sequential treatment with saponin and Nonidet P-40 was used to fractionate tyrosine-phosphorylated proteins during Thy-1-mediated activation of RBL-2H3 cells. Among the soluble cytoplasmic proteins the most dramatic change in tyrosine phosphorylation was found in pp72, whereas pp40 and pp33 were found mainly in the membrane fraction. Our data suggest that surface aggregation of GPI-anchored Thy-1 molecules leads to aggregation of p56/p53lyn kinase located in the same membrane microdomain, followed by transphosphorylation of both soluble and membrane-bound substrates.

Zobrazit více v PubMed

J Biol Chem. 1994 Feb 18;269(7):5249-54 PubMed

J Cell Biol. 1992 Jul;118(1):63-9 PubMed

J Immunol. 1992 Oct 1;149(7):2262-70 PubMed

J Immunol. 1992 Dec 1;149(11):3535-41 PubMed

J Biol Chem. 1993 Feb 15;268(5):3150-5 PubMed

Eur J Immunol. 1993 Apr;23(4):825-31 PubMed

Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3611-5 PubMed

Immunol Today. 1993 May;14(5):222-6 PubMed

Immunology. 1993 Sep;80(1):103-9 PubMed

J Cell Biol. 1994 Jul;126(1):111-26 PubMed

J Cell Biol. 1994 Jul;126(2):353-63 PubMed

Mol Cell Biol. 1994 Aug;14(8):5384-91 PubMed

Proc Natl Acad Sci U S A. 1994 Nov 8;91(23):11246-50 PubMed

Biochim Biophys Acta. 1984 Jun 13;773(1):32-8 PubMed

Mol Cell Biol. 1987 Jan;7(1):237-43 PubMed

Biochem J. 1988 Mar 15;250(3):865-9 PubMed

FASEB J. 1989 Mar;3(5):1600-8 PubMed

Eur J Immunol. 1989 Sep;19(9):1715-20 PubMed

J Immunol. 1990 Dec 1;145(11):3814-22 PubMed

J Cell Biol. 1990 Dec;111(6 Pt 2):2931-8 PubMed

Eur J Immunol. 1991 Jul;21(7):1583-90 PubMed

Science. 1991 Nov 15;254(5034):1016-9 PubMed

Proc Natl Acad Sci U S A. 1992 Jan 1;89(1):222-6 PubMed

Proc Natl Acad Sci U S A. 1992 Feb 1;89(3):1118-22 PubMed

Cell. 1992 Feb 7;68(3):533-44 PubMed

Proc Natl Acad Sci U S A. 1992 Apr 1;89(7):2945-9 PubMed

J Biol Chem. 1994 Dec 9;269(49):30745-8 PubMed

J Cell Sci. 1994 Jul;107 ( Pt 7):1783-96 PubMed

J Biol Chem. 1992 Jun 15;267(17):12317-22 PubMed

Nature. 1970 Aug 15;227(5259):680-5 PubMed

Eur J Immunol. 1979 Nov;9(11):875-86 PubMed

Biochem J. 1980 Apr 1;187(1):1-20 PubMed

Anal Biochem. 1984 Feb;136(2):458-64 PubMed

Science. 1994 Jun 24;264(5167):1948-51 PubMed

Nejnovějších 20 citací...

Zobrazit více v
Medvik | PubMed

ORMDL2 Deficiency Potentiates the ORMDL3-Dependent Changes in Mast Cell Signaling

. 2020 ; 11 () : 591975. [epub] 20210211

Cytoskeletal Protein 4.1R Is a Positive Regulator of the FcεRI Signaling and Chemotaxis in Mast Cells

. 2019 ; 10 () : 3068. [epub] 20200114

Positive and Negative Regulatory Roles of C-Terminal Src Kinase (CSK) in FcεRI-Mediated Mast Cell Activation, Independent of the Transmembrane Adaptor PAG/CSK-Binding Protein

. 2018 ; 9 () : 1771. [epub] 20180802

Negative regulatory roles of ORMDL3 in the FcεRI-triggered expression of proinflammatory mediators and chemotactic response in murine mast cells

. 2016 Mar ; 73 (6) : 1265-85. [epub] 20150925

Ethanol Inhibits High-Affinity Immunoglobulin E Receptor (FcεRI) Signaling in Mast Cells by Suppressing the Function of FcεRI-Cholesterol Signalosome

. 2015 ; 10 (12) : e0144596. [epub] 20151214

Transmembrane adaptor protein PAG/CBP is involved in both positive and negative regulation of mast cell signaling

. 2014 Dec 01 ; 34 (23) : 4285-300. [epub] 20140922

Cross-talk between tetraspanin CD9 and transmembrane adaptor protein non-T cell activation linker (NTAL) in mast cell activation and chemotaxis

. 2013 Apr 05 ; 288 (14) : 9801-9814. [epub] 20130226

Down-regulation of protein-tyrosine phosphatases activates an immune receptor in the absence of its translocation into lipid rafts

. 2010 Apr 23 ; 285 (17) : 12787-802. [epub] 20100215

Structure-function analysis of Lyn kinase association with lipid rafts and initiation of early signaling events after Fcepsilon receptor I aggregation

. 2001 Dec ; 21 (24) : 8318-28.

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...